← FDA Drug Approvals (Drugs@FDA)

IBSRELA

NDA · New Drug Application · Sponsor: ARDELYX INC · Approved 2019-09-12

Drug application

FDA Application #
NDA211801
Application type
New Drug Application
Brand name
IBSRELA
Generic name
TENAPANOR HYDROCHLORIDE
Active ingredients
TENAPANOR HYDROCHLORIDE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
ARDELYX INC
Manufacturer
Ardelyx, Inc.
First approval
2019-09-12

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown